Viral hepatitis C pandemic: Challenges and threats to its elimination

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F21%3A00081009" target="_blank" >RIV/00023001:_____/21:00081009 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/21:10427864

Výsledek na webu

<a href="https://onlinelibrary.wiley.com/doi/10.1111/jvh.13480" target="_blank" >https://onlinelibrary.wiley.com/doi/10.1111/jvh.13480</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1111/jvh.13480" target="_blank" >10.1111/jvh.13480</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Viral hepatitis C pandemic: Challenges and threats to its elimination

Popis výsledku v původním jazyce

Under the WHO plan, the global elimination of the HCV pandemic is scheduled for 2030. The burden of HCV infection in developed countries is largely borne by people who inject drugs (PWID): new infections and reinfections are related to their risky behaviour. Although safe and sensitive hepatitis C diagnostic tools and directly acting antiviral medication are widely used, major challenges to disease elimination still remain in developed countries, where the WHO plan is in progress. The challenge is in the involvement and engagement of infected PWID. There is a strong need to change our uptake and treatment strategies to address all patients from the risk groups, connect them with the healthcare system and cure them with the vision to eliminate this HCV pandemic.

Název v anglickém jazyce

Viral hepatitis C pandemic: Challenges and threats to its elimination

Popis výsledku anglicky

Under the WHO plan, the global elimination of the HCV pandemic is scheduled for 2030. The burden of HCV infection in developed countries is largely borne by people who inject drugs (PWID): new infections and reinfections are related to their risky behaviour. Although safe and sensitive hepatitis C diagnostic tools and directly acting antiviral medication are widely used, major challenges to disease elimination still remain in developed countries, where the WHO plan is in progress. The challenge is in the involvement and engagement of infected PWID. There is a strong need to change our uptake and treatment strategies to address all patients from the risk groups, connect them with the healthcare system and cure them with the vision to eliminate this HCV pandemic.

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30303 - Infectious Diseases

Projekt

—

Návaznosti

N - Vyzkumna aktivita podporovana z neverejnych zdroju

Rok uplatnění

2021

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of viral hepatitis

ISSN

1352-0504

e-ISSN

—

Svazek periodika

28

Číslo periodika v rámci svazku

5

Stát vydavatele periodika

GB - Spojené království Velké Británie a Severního Irska

Počet stran výsledku

5

Strana od-do

694-698

Kód UT WoS článku

000621123200001

EID výsledku v databázi Scopus

2-s2.0-85101494495